jumbotron_hero
two_columns

Accelerating elimination of onchocerciasis in Cameroon

Working men taking a break

In Cameroon, onchocerciasis (river blindness) is endemic in all ten regions,
with approximately six million people infected, or about 60% of the population.  

GLIDE is collaborating with Ministry of Health in Cameroon that jointly works with the Centre for Research on Filariasis and other Tropical Diseases (CRFilMT) and the Catholic University of Central Africa (UCAC) to support a study on community attitudes and perceptions towards mass drug administration (MDA) with ivermectin. The findings of the study will help to inform National Onchocerciasis Programme on barriers and challenges and identify opportunities for the Programme to facilitate greater levels of community involvement.    

More Programmes

Locals in Malawi river

Malawi Onchocerciasis Transmission Assessment

We support the Malawi Onchocerciasis Control Program (MOCP) Transmission Assessment activities for Neno and Chiradzulu.
Hands passing medicine

Sightsavers

Working with Sightsavers, we are developing and trialing a low-cost, high-impact strategy for determining river blindness transmission across borders.
Person receiving injection

Challenging Anti-Vaccine Sentiments

We work with New York University, UNICEF, WHO EMRO and the AUB to tackle the challenge of rising anti-vaccine and anti-science sentiment.